Found: 29
Select item for more details and to access through your institution.
Association of large joint involvement at the start of biological disease‐modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 3, p. 1, doi. 10.1111/1756-185X.15097
- By:
- Publication type:
- Article
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. 349, doi. 10.1093/rheumatology/kead299
- By:
- Publication type:
- Article
Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 5, p. 928, doi. 10.1093/mr/roac115
- By:
- Publication type:
- Article
Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 4, p. 690, doi. 10.1093/mr/roac092
- By:
- Publication type:
- Article
Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7399, doi. 10.3390/ijms24087399
- By:
- Publication type:
- Article
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 4, p. 834, doi. 10.1093/mr/roab043
- By:
- Publication type:
- Article
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Rheumatology International, 2022, v. 42, n. 7, p. 1227, doi. 10.1007/s00296-021-05086-w
- By:
- Publication type:
- Article
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04075-0
- By:
- Publication type:
- Article
A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis.
- Published in:
- Journal of Inflammation Research, 2021, v. 14, p. 3721, doi. 10.2147/JIR.S323577
- By:
- Publication type:
- Article
A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis.
- Published in:
- Journal of Inflammation Research, 2021, v. 14, p. 3721, doi. 10.2147/JIR.S323577
- By:
- Publication type:
- Article
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 7, p. 2673, doi. 10.1007/s10067-021-05609-7
- By:
- Publication type:
- Article
Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
- Published in:
- Rheumatology International, 2021, v. 41, n. 7, p. 1233, doi. 10.1007/s00296-021-04862-y
- By:
- Publication type:
- Article
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02496-w
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study.
- Published in:
- Rheumatology International, 2020, v. 40, n. 12, p. 1987, doi. 10.1007/s00296-020-04660-y
- By:
- Publication type:
- Article
Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. N.PAG, doi. 10.1186/s13075-020-02356-z
- By:
- Publication type:
- Article
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 9, p. 2563, doi. 10.1007/s10067-020-05015-5
- By:
- Publication type:
- Article
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02232-w
- By:
- Publication type:
- Article
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study
- Published in:
- Rheumatology International, 2020, v. 40, n. 2, p. 217, doi. 10.1007/s00296-019-04464-9
- By:
- Publication type:
- Article
Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216624
- By:
- Publication type:
- Article
Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1880-4
- By:
- Publication type:
- Article
Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1673-1
- By:
- Publication type:
- Article
Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194130
- By:
- Publication type:
- Article
Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effective intravenous immunoglobulin therapy for Churg-Strauss syndrome (allergic granulomatous angiitis) complicated by neuropathy of the eighth cranial nerve: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A case of rheumatoid pericarditis associated with a high IL-6 titer in the pericardial fluid and tocilizumab treatment.
- Published in:
- Modern Rheumatology, 2011, v. 21, n. 3, p. 302, doi. 10.3109/s10165-010-0377-4
- By:
- Publication type:
- Article
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 73, p. 1, doi. 10.1126/scitranslmed.3001180
- By:
- Publication type:
- Article
Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells.
- Published in:
- International Immunology, 2008, v. 20, n. 10, p. 1321, doi. 10.1093/intimm/dxn094
- By:
- Publication type:
- Article
Successful treatment with plasma exchange in adult-onset Still’s disease with hyper-IL-18-naemia and hyperallergic state.
- Published in:
- Modern Rheumatology, 2008, v. 18, n. 4, p. 407, doi. 10.3109/s10165-008-0065-9
- By:
- Publication type:
- Article